Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

copper Cu 64 NODAGA-TTX-MC138

A radioconjugate comprised of the microRNA-10b (miR-10b)-inhibitor TTX-MC138, which consists of an anti-miR10b antagomir conjugated to ultrasmall iron oxide nanoparticles, chelated with 1,4,7-triazacyclononane,1-glutaric acid-4,7 acetic acid (NODAGA) and radiolabeled with the radiotracer copper Cu 64, that may be used as an imaging agent for miR-10b-overexpressing tumor cells upon positron emission tomography (PET)-magnetic resonance imaging (PET-MRI). Upon administration of copper Cu 64 NODAGA- TTX-MC138, the TTX-MC138 moiety targets and binds to miR-10b inside tumor cells. This allows for visualization of miR-10b-overexpressing tumor cells upon imaging with PET-MRI. miR-10b, a mRNA that is highly expressed in a variety of metastatic tumor cells, plays a key role in tumor cell migration, invasion and metastasis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:64Cu-NODAGA-TTX-MC138
Cu-64 labeled TTX-MC138
Code name:TTX-MC138-NODAGA-Cu64
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search